After the article was published last August, Avantor said it stopped all Mexican and Latin American sales of the chemical, and has said it sold only to authorized buyers and complied with all Mexican laws.
Gupta said she was aware of Bloomberg’s findings and that in addition to selling shares she controls -- as she previously proposed -- the trustee of shares in two family trusts intends to sell off the Avantor stock at the first available opportunity.
“As a shareholder with no role in Avantor, I am not able to say whether and how much I have profited from the various parts of Avantor’s business,” she told Grassley.
Gupta said in other answers to the Judiciary Committee that she has about $5.1 million in Avantor-derived assets she controls and about about $13 million via the two family trusts that she doesn’t control.
Andrew Bates, a spokesman for President Joe Biden’s transition, said about $3.75 million of the $5.1 million she controls was a cash distribution from a family trust from previous Avantor holdings, leaving her with a $14.5 million stake in the company now.
Her financial statement gave a range of $11 million to $55 million for her Avantor holdings, and she noted she has previously committed to recusing herself from matters involving Avantor.
During Gupta’s Judiciary Committee confirmation hearing last week, Republicans challenged her previous statements calling for decriminalizing the possession of small amounts of all drugs. She said she no longer holds that position and told Grassley she sees no conflict of interest with her views on illegal drugs.
The committee is expected to vote on the nomination next week. Gupta, who ran the Justice Department’s civil rights division under President
(Updates with details on Gupta’s Avantor holdings starting in first paragraph.)
To contact the editors responsible for this story:
Larry Liebert, Flynn McRoberts
© 2021 Bloomberg L.P. All rights reserved. Used with permission.